HEPATITIS B

This early-stage study tested a new hepatitis B vaccine that includes an experimental booster called AS37. The goal was to see if the vaccine is safe and triggers a strong immune response. 122 healthy adults aged 18-45 received two doses, and researchers monitored side effects an…

This study looked at the safety of the Hexaxim vaccine, which protects against diseases like hepatitis B and Haemophilus influenzae type b, in infants starting at 2 months old in South Korea. Researchers tracked side effects like pain, swelling, fever, and crying in 713 babies wh…

This study looked at whether giving young children just two doses of the hepatitis B vaccine works as well as the usual three doses. Over 400 children took part, receiving different vaccine schedules. The goal was to see if a simpler schedule still provides strong protection agai…

This study tested whether a double-dose hepatitis B vaccine (40 micrograms) works better than the standard dose (20 micrograms) in people with HIV who had not responded to previous hepatitis B vaccines. The trial included 178 participants and measured how many developed protectiv…

This study tested an experimental drug called ARO-HBV in 114 people, including healthy volunteers and patients with chronic hepatitis B. The main goal was to check if the drug is safe and how the body processes it. Researchers gave single or multiple doses and monitored side effe…

This study tested an experimental oral drug called selgantolimod in 29 adults who have both chronic hepatitis B and HIV and have been on stable antiviral therapy for at least 5 years. The goal was to see if the drug is safe and can reduce hepatitis B surface antigen (HBsAg) level…

This study tested a strategy of using rapid point-of-care tests to screen pregnant women for sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis during routine antenatal visits in Zimbabwe. Over 1,000 women participated to see if immediate testing and t…

This study tested whether giving pregnant women with hepatitis B a daily pill (tenofovir) plus a vaccine at birth can safely prevent passing the virus to their babies. Over 300 mothers in the Democratic Republic of Congo took part, and researchers tracked safety and how well the …

This study looks at hepatitis C virus (HCV) infection in blood donors who tested positive for it. The goal is to learn how the virus spreads, how many people develop liver disease, and what happens over time. About 805 participants will give blood samples and answer health questi…

This study looked at how many people held in the Nîmes administrative detention center have HIV, hepatitis B, or hepatitis C. Researchers used rapid tests to get results quickly, since many detainees leave before standard lab results come back. The goal was to find out how common…

This study tested 892 African and Asian immigrants in Minnesota for hepatitis B and C to understand how common these infections are and how they increase the risk of liver cancer. Researchers also looked at viral genetics and immune responses. No treatment was given; the goal was…

This study looked at whether doctors followed guidelines to screen COVID-19 patients for hepatitis B before giving them steroids. Researchers tracked 1793 hospitalized adults to see if the virus reactivated. The goal was to understand risks and improve safety in a country with lo…